Baxter (BAX) Tops Q4 EPS by 5c, Offers Q1 and FY Guidance

Baxter (NYSE: BAX) reported Q4 EPS of $0.78, $0.05 better than the analyst estimate of $0.73. Revenue for the quarter came in at $2.8 billion versus the consensus estimate of $2.8 billion.

GUIDANCE:

Baxter sees Q1 2019 EPS of $0.66-$0.68, versus the consensus of $0.74.

• The company expects sales to decline approximately 3 percent on a reported basis, to increase approximately 1 percent on a constant currency basis and to grow approximately 1 to 2 percent on an operational basis

Baxter sees FY2019 EPS of $3.22-$3.30, versus the consensus of $3.27.

• For full-year 2019: Baxter expects sales growth of 0 to 1 percent on a reported basis, 2 to 3 percent on a constant currency basis and 3 to 4 percent on an operational basis

For earnings history and earnings-related data on Baxter (BAX) click here.

You May Also Be Interested In

• Biogen (BIIB) tops earnings expectations but revenue falls short
• Masco Corp. (MAS) Tops Q1 EPS by 5c; offers guidance
• Greene County Bancorp, Inc. (GCBC) Reports Q3 EPS of $0.34